ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382054 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382054; 2) Community: the network communities that were significantly associated with the response to NSC 382054; 3) Molecule: the relationships between components within communities and NSC 382054; 4) MDR: the compounds that were significantly associated with the NSC 382054.

NSC Compound Enrichment Correlation
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0237269271456697 0.30844722
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.0237269271456697 0.096643751
NSC 709974 Null 0.0237269271456697 0.47335108
NSC 718564 Null 0.0237269271456697 -0.012909098
NSC 718781 Erlotinib hydrochloride 0.0237269271456697 -0.15076938
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0237269271456697 0.0071628787
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.0237269271456697 0.36016634
NSC 726217 Combretastatin A4-analogue 0.0237269271456697 0.46438233
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0237269271456697 0.12099979
NSC 744688 Null 0.0237269271456697 0.47634032
Total:156  Current:106    [First] [Prev] [Next] [Last]